272 related articles for article (PubMed ID: 28834447)
1. Revisiting Nonmass Enhancement in Breast MRI: Analysis of Outcomes and Follow-Up Using the Updated BI-RADS Atlas.
Chikarmane SA; Michaels AY; Giess CS
AJR Am J Roentgenol; 2017 Nov; 209(5):1178-1184. PubMed ID: 28834447
[TBL] [Abstract][Full Text] [Related]
2. Interobserver variability and likelihood of malignancy for fifth edition BI-RADS MRI descriptors in non-mass breast lesions.
Lunkiewicz M; Forte S; Freiwald B; Singer G; Leo C; Kubik-Huch RA
Eur Radiol; 2020 Jan; 30(1):77-86. PubMed ID: 31392476
[TBL] [Abstract][Full Text] [Related]
3. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
4. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
[TBL] [Abstract][Full Text] [Related]
6. Discriminative Factors of Malignancy of Ipsilateral Nonmass Enhancement in Women With Newly Diagnosed Breast Cancer on Initial Staging Breast MRI.
Jirarayapong J; Chikarmane SA; Portnow LH; Farah S; Gombos EC
J Magn Reson Imaging; 2024 May; 59(5):1725-1739. PubMed ID: 37534882
[TBL] [Abstract][Full Text] [Related]
7. The MRI characteristics of non-mass enhancement lesions of the breast: associations with malignancy.
Aydin H
Br J Radiol; 2019 Apr; 92(1096):20180464. PubMed ID: 30673299
[TBL] [Abstract][Full Text] [Related]
8. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
[TBL] [Abstract][Full Text] [Related]
9. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
El Khoury M; Lalonde L; David J; Labelle M; Mesurolle B; Trop I
Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
[TBL] [Abstract][Full Text] [Related]
10. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
[TBL] [Abstract][Full Text] [Related]
11. Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography.
Hsu HH; Chang TH; Chou YC; Peng YJ; Ko KH; Chang WC; Lin YP; Hsu GC; Yu JC
Breast J; 2015; 21(6):579-87. PubMed ID: 26390913
[TBL] [Abstract][Full Text] [Related]
12. Significance of Additional Non-Mass Enhancement in Patients with Breast Cancer on Preoperative 3T Dynamic Contrast Enhanced MRI of the Breast.
Cho YH; Cho KR; Park EK; Seo BK; Woo OH; Cho SB; Bae JW
Iran J Radiol; 2016 Jan; 13(1):e30909. PubMed ID: 27127579
[TBL] [Abstract][Full Text] [Related]
13. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
[TBL] [Abstract][Full Text] [Related]
14. Patterns of malignant non-mass enhancement on 3-T breast MRI help predict invasiveness: using the BI-RADS lexicon fifth edition.
Lee SM; Nam KJ; Choo KS; Kim JY; Jeong DW; Kim HY; Kim JY
Acta Radiol; 2018 Nov; 59(11):1292-1299. PubMed ID: 29758996
[TBL] [Abstract][Full Text] [Related]
15. Two Distinct Types of Linear Distribution in Nonmass Enhancement at Breast MR Imaging: Difference in Positive Predictive Value between Linear and Branching Patterns.
Machida Y; Tozaki M; Shimauchi A; Yoshida T
Radiology; 2015 Sep; 276(3):686-94. PubMed ID: 25875971
[TBL] [Abstract][Full Text] [Related]
16. Grading system to categorize breast MRI using BI-RADS 5th edition: a statistical study of non-mass enhancement descriptors in terms of probability of malignancy.
Asada T; Yamada T; Kanemaki Y; Fujiwara K; Okamoto S; Nakajima Y
Jpn J Radiol; 2018 Mar; 36(3):200-208. PubMed ID: 29285740
[TBL] [Abstract][Full Text] [Related]
17. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
[TBL] [Abstract][Full Text] [Related]
18. Morphology evaluation of nonmass enhancement on breast MRI: Effect of a three-step interpretation model for readers' performances and biopsy recommendations.
Shimauchi A; Ota H; Machida Y; Yoshida T; Satani N; Mori N; Takase K; Tozaki M
Eur J Radiol; 2016 Feb; 85(2):480-8. PubMed ID: 26781155
[TBL] [Abstract][Full Text] [Related]
19. High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors.
Tozaki M; Fukuda K
AJR Am J Roentgenol; 2006 Aug; 187(2):330-7. PubMed ID: 16861534
[TBL] [Abstract][Full Text] [Related]
20. Can we apply the MRI BI-RADS lexicon morphology descriptors on contrast-enhanced spectral mammography?
Kamal RM; Helal MH; Mansour SM; Haggag MA; Nada OM; Farahat IG; Alieldin NH
Br J Radiol; 2016 Aug; 89(1064):20160157. PubMed ID: 27327403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
